The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
AB5075, a Highly Virulent Isolate of Acinetobacter baumannii, as a Model Strain for the Evaluation of Pathogenesis and Antimicrobial Treatments
Open accessAbstract
Acinetobacter baumannii is recognized as an emerging bacterial pathogen because of traits such as prolonged survival in a desiccated state, effective nosocomial transmission, and an inherent ability to acquire antibiotic resistance genes. A pressing need in the field of A. baumannii research is a suitable model strain that is representative of current clinical isolates, is highly virulent in established animal models, and can be genetically manipulated. To identify a suitable strain, a genetically diverse set of recent U.S. military clinical isolates was assessed. Pulsed-field gel electrophoresis and multiplex PCR determined the genetic diversity of 33 A. baumannii isolates. Subsequently, five representative isolates were tested in murine pulmonary and Galleria mellonella models of infection. Infections with one strain, AB5075, were considerably more severe in both animal models than those with other isolates, as there was a significant decrease in survival rates. AB5075 also caused osteomyelitis in a rat open fracture model, while another isolate did not. Additionally, a Tn 5 transposon library was successfully generated in AB5075, and the insertion of exogenous genes into the AB5075 chromosome via Tn 7 was completed, suggesting that this isolate may be genetically amenable for research purposes. Finally, proof-of-concept experiments with the antibiotic rifampin showed that this strain can be used in animal models to assess therapies under numerous parameters, including survival rates and lung bacterial burden. We propose that AB5075 can serve as a model strain for A. baumannii pathogenesis due to its relatively recent isolation, multidrug resistance, reproducible virulence in animal models, and genetic tractability. IMPORTANCE The incidence of A. baumannii infections has increased over the last decade, and unfortunately, so has antibiotic resistance in this bacterial species. A. baumannii is now responsible for more than 10% of all hospital-acquired infections in the United States and has a >50% mortality rate in patients with sepsis and pneumonia. Most research on the pathogenicity of A. baumannii focused on isolates that are not truly representative of current multidrug-resistant strains isolated from patients. After screening of a panel of isolates in different in vitro and in vivo assays, the strain AB5075 was selected as more suitable for research because of its antibiotic resistance profile and increased virulence in animal models. Moreover, AB5075 is susceptible to tetracycline and hygromycin, which makes it amenable to genetic manipulation. Taken together, these traits make AB5075 a good candidate for use in studying virulence and pathogenicity of this species and testing novel antimicrobials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guide for the Care and Use of Laboratory Animals: Eighth Edition
(2011) · doi:10.17226/12910 · Cited by 16,199
Guide for the Care and Use of Laboratory Animals (8th edn)
Albus, U. (2012) · Laboratory Animals · doi:10.1258/la.2012.150312 · Cited by 1,693
Clinical relevance of the ESKAPE pathogens
Pendleton, J. N., Gorman, S. P., & Gilmore, B. F. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.13.12 · Cited by 1,423
Comprehensive transposon mutant library of Pseudomonas aeruginosa
Jacobs, M. A., Alwood, A., Thaipisuttikul, I., Spencer, D., Haugen, E., Ernst, S., Will, O., Kaul, R., Raymond, C., Levy, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2036282100 · Cited by 1,126
Guidelines for the validation and application of typing methods for use in bacterial epidemiology
van Belkum, A., Tassios, P. T., Dijkshoorn, L., Haeggman, S., Cookson, B., Fry, N. K., Fussing, V., Green, J., Feil, E., Gerner-Smidt, P., et al. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01786.x · Cited by 863
A Tn7-based broad-range bacterial cloning and expression system
Choi, K.-H., Gaynor, J. B., White, K. G., Lopez, C., Bosio, C. M., Karkhoff-Schweizer, R. R., & Schweizer, H. P. (2005) · Nature Methods · doi:10.1038/nmeth765 · Cited by 828
Tomaras, A. P., Dorsey, C. W., Edelmann, R. E., & Actis, L. A. (2003) · Microbiology · doi:10.1099/mic.0.26541-0 · Cited by 599
Self-citationHujer, K. M., Hujer, A. M., Hulten, E. A., Bajaksouzian, S., Adams, J. M., Donskey, C. J., Ecker, D. J., Massire, C., Eshoo, M. W., Sampath, R., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00778-06 · Cited by 480
Self-citationSmith, M. G., Gianoulis, T. A., Pukatzki, S., Mekalanos, J. J., Ornston, L. N., Gerstein, M., & Snyder, M. (2007) · Genes & Development · doi:10.1101/gad.1510307 · Cited by 474
Comparative Genome Sequence Analysis of Multidrug-Resistant Acinetobacter baumannii
Adams, M. D., Goglin, K., Molyneaux, N., Hujer, K. M., Lavender, H., Jamison, J. J., MacDonald, I. J., Martin, K. M., Russo, T., Campagnari, A. A., et al. (2008) · Journal of Bacteriology · doi:10.1128/jb.00834-08 · Cited by 435
Galleria mellonella as a Model System To Study Acinetobacter baumannii Pathogenesis and Therapeutics
Peleg, A. Y., Jara, S., Monga, D., Eliopoulos, G. M., Moellering, R. C., & Mylonakis, E. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01533-08 · Cited by 320
Identification and Characterization of an Acinetobacter baumannii Biofilm-Associated Protein
Loehfelm, T. W., Luke, N. R., & Campagnari, A. A. (2008) · Journal of Bacteriology · doi:10.1128/jb.01416-07 · Cited by 279
Visualization of comparative genomic analyses by BLAST score ratio
Rasko, D. A., Myers, G. S., & Ravel, J. (2005) · BMC Bioinformatics · doi:10.1186/1471-2105-6-2 · Cited by 267
Self-citationDeciphering the Multifactorial Nature of Acinetobacter baumannii Pathogenicity
Antunes, L. C. S., Imperi, F., Carattoli, A., & Visca, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022674 · Cited by 244
Gaddy, J. A., Arivett, B. A., McConnell, M. J., López-Rojas, R., Pachón, J., & Actis, L. A. (2012) · Infection and Immunity · doi:10.1128/iai.06279-11 · Cited by 241
Self-citationZlowodzki, M., Ayieni, O., Petrisor, B. A., & Bhandari, M. (2008) · Journal of Trauma: Injury, Infection & Critical Care · doi:10.1097/01.ta.0000241143.71274.63 · Cited by 209
Lesho, E., Yoon, E.-J., McGann, P., Snesrud, E., Kwak, Y., Milillo, M., Onmus-Leone, F., Preston, L., St. Clair, K., Nikolich, M., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit293 · Cited by 171
Self-citationThe Rise of Carbapenem-Resistant Acinetobacter baumannii
Evans, B. A., Hamouda, A., & Amyes, S. G. B. (2012) · Current Pharmaceutical Design · doi:10.2174/138161213804070285 · Cited by 157
Desbois, A. P., & Coote, P. J. (2012) · Advances in applied microbiology · doi:10.1016/b978-0-12-394805-2.00002-6 · Cited by 135
The Rise of Carbapenem-Resistant Acinetobacter baumannii
Evans, B. A., Hamouda, A., & Amyes, S. G. B. (2012) · Current Pharmaceutical Design · doi:10.2174/1381612811306020223 · Cited by 129
Septic Complications of War Wounds
Tong, M. J. (1972) · JAMA · doi:10.1001/jama.1972.03190340050011 · Cited by 125
The virulence variability of different Acinetobacter baumannii strains in experimental pneumonia
Eveillard, M., Soltner, C., Kempf, M., Saint‐André, J., Lemarié, C., Randrianarivelo, C., Seifert, H., Wolff, M., & Joly‐Guillou, M. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.09.004 · Cited by 98
Sequence-Defined Transposon Mutant Library of Burkholderia thailandensis
Gallagher, L. A., Ramage, E. R., Patrapuvich, R., Weiss, E. J., Brittnacher, M. J., & Manoil, C. (2013) · mBio · doi:10.1128/mbio.00604-13 · Cited by 94
Validation of a Novel Murine Wound Model of Acinetobacter baumannii Infection
Thompson, M. G., Black, C. C., Pavlicek, R. L., Honnold, C. L., Wise, M. C., Alamneh, Y. A., Moon, J. K., Kessler, J. L., Si, Y., Williams, R. H., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01944-13 · Cited by 87
Self-citationTherapeutic options forAcinetobacter baumanniiinfections: an update
Vilà, J., & Pachón, J. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.729820 · Cited by 85
Sahl, J. W., Johnson, J. K., Harris, A. D., Phillippy, A. M., Hsiao, W., Thom, K. A., & Rasko, D. A. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-291 · Cited by 76
Self-citationRat Pneumonia and Soft-Tissue Infection Models for the Study of Acinetobacter baumannii Biology
Russo, T. A., Beanan, J. M., Olson, R., MacDonald, U., Luke, N. R., Gill, S. R., & Campagnari, A. A. (2008) · Infection and Immunity · doi:10.1128/iai.00269-08 · Cited by 62
Safdar, A. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01571.x · Cited by 61
Acinetobacter Infection in the ICU
Murray, C. K., & Hospenthal, D. R. (2008) · Critical Care Clinics · doi:10.1016/j.ccc.2007.12.005 · Cited by 49
de Breij, A., Eveillard, M., Dijkshoorn, L., van den Broek, P. J., Nibbering, P. H., & Joly‐Guillou, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030673 · Cited by 48
Manepalli, S., Gandhi, J. A., Ekhar, V. V., Asplund, M. B., Coelho, C., & Martinez, L. R. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.060004-0 · Cited by 46
Genetic Features of CTX-M-15-Producing Acinetobacter baumannii from Haiti
Potron, A., Munoz-Price, L. S., Nordmann, P., Cleary, T., & Poirel, L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05124-11 · Cited by 44
Buchan, B. W., McLendon, M. K., & Jones, B. D. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.02882-07 · Cited by 37
The microbiological characteristics of patients with crush syndrome after the Wenchuan earthquake
Wang, T., Li, D., Xie, Y., Kang, M., Chen, Z., Chen, H., Fan, H. S., Wang, L., & Tao, C. (2010) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365541003671226 · Cited by 18
Acinetobacter baumannii is not Associated with Osteomyelitis in a Rat Model: A Pilot Study
Collinet‐Adler, S., Castro, C. A., Ledonio, C. G. T., Bechtold, J. E., & Tsukayama, D. T. (2010) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-010-1488-0 · Cited by 16
Automating Genomic Data Mining via a Sequence-based Matrix Format and Associative Rule Set
Wren, J. D., Johnson, D. K., & Gruenwald, L. (2005) · BMC Bioinformatics · doi:10.1186/1471-2105-6-s2-s2 · Cited by 10
Cited by
Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges
Wong, D., Nielsen, T. B., Bonomo, R. A., Pantapalangkoor, P., Luna, B., & Spellberg, B. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-16 · Cited by 1,170
Uncovering the mechanisms of Acinetobacter baumannii virulence
Harding, C. M., Hennon, S. W., & Feldman, M. F. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.148 · Cited by 1,026
Tsai, C. J.-Y., Loh, J. M. S., & Proft, T. (2016) · Virulence · doi:10.1080/21505594.2015.1135289 · Cited by 778
Bacteriophage-resistant Acinetobacter baumannii are resensitized to antimicrobials
Gordillo Altamirano, F., Forsyth, J. H., Patwa, R., Kostoulias, X., Trim, M., Subedi, D., Archer, S. K., Morris, F. C., Oliveira, C., Kielty, L., et al. (2021) · Nature Microbiology · doi:10.1038/s41564-020-00830-7 · Cited by 349
Resources for Genetic and Genomic Analysis of Emerging Pathogen Acinetobacter baumannii
Gallagher, L. A., Ramage, E., Weiss, E. J., Radey, M., Hayden, H. S., Held, K. G., Huse, H. K., Zurawski, D. V., Brittnacher, M. J., & Manoil, C. (2015) · Journal of Bacteriology · doi:10.1128/jb.00131-15 · Cited by 291
Self-citation
Metadata
- Authors
- Jacobs, A. C., Thompson, M. G., Black, C. C., Kessler, J. L., Clark, L. P., McQueary, C. N., Gancz, H. Y., Corey, B. W., Moon, J. K., Si, Y., Owen, M. T., Hallock, J. D., Kwak, Y. I., Summers, A., Li, C. Z., Rasko, D. A., Penwell, W. F., Honnold, C. L., Wise, M. C., Waterman, P. E., Lesho, E. P., Stewart, R. L., Actis, L. A., Palys, T. J., Craft, D. W., & Zurawski, D. V.
- Venue
- mBio
- Publisher
- American Society for Microbiology
- Published
- 2014-07
- Volume
- 5
- Issue
- 3
- Pages
- e01076-14
- ISSN
- 2150-7511 (ISSN-L)
- 2161-2129
- OpenAlex
- W2102749349
- Cited by
- 328
- References
- 36
- FWCI
- 7.36
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.